T
he klotho gene, which was originally identified as an aging suppressor gene in mice, encodes a single-pass transmembrane protein that is predominantly expressed in the distal tubular epithelial cells of the kidneys and choroid plexus of the brain. [1] [2] [3] [4] Insertional mutation of mouse klotho gene results in extensive premature aging phenotypes and shortens lifespan. 1 However, overexpression of mouse klotho gene rescued aging phenotypes and extended lifespan by 20% to 30%. 5 Therefore, klotho is an antiaging gene. 3 Arterial stiffness is one of the earliest detectable manifestations of adverse structural and functional changes within the vessel wall. Increased stiffness of large conduit arteries is a major risk factor for hypertension. 6, 7 It has also been shown that arterial stiffness is an independent predictor of stroke and ischemic heart disease. 8 The wall of large arteries, especially the aorta, thickens and loses elasticity over time, which results in an increase in arterial stiffness. 7 Elastin and collagen fibers are major determinants of mechanical properties of large arteries. 9, 10 Large conduit arteries become stiffer with age because of fragmentation and degradation of elastin and subsequent replacement by collagen, which is 100 to 1000× stiffer than elastin. 11 Large-artery stiffening may be influenced by aging, hemodynamic forces, and excessive hormones, such as aldosterone. [12] [13] [14] It was reported that patients with hyperaldosteronism have increased arterial stiffness. 15 Although excessive aldosterone may be involved in arterial stiffness, 16 the underlying mechanism has yet to be determined.
The klotho level decreases with age, 17 whereas the prevalence of arterial stiffness increases with age. 18 At the age of 70 years, the serum level of klotho is less than one half of what it was at the age of 40 years. 17 Moreover, the serum klotho level is significantly decreased in patients with arterial stiffness Abstract-The prevalence of arterial stiffness increases with age, whereas the level of the aging-suppressor protein klotho decreases with age. The objective of this study is to assess whether haplodeficiency of klotho gene causes arterial stiffness and to investigate the underlying mechanism. Pulse wave velocity, a direct measure of arterial stiffness, was increased significantly in klotho heterozygous (klotho +/− ) mice versus their age-matched wild-type (WT) littermates, suggesting that haplodeficiency of klotho causes arterial stiffening. Notably, plasma aldosterone levels were elevated significantly in klotho +/− mice. Treatment with eplerenone (6 mg/kg per day IP), an aldosterone receptor blocker, abolished klotho deficiency-induced arterial stiffening in klotho +/− mice. Klotho deficiency was associated with increased collagen and decreased elastin contents in the media of aortas. In addition, arterial matrix metalloproteinase-2, matrix metalloproteinase-9, and transforming growth factor-β1 expression and myofibroblast differentiation were increased in klotho +/− mice. These klotho deficiency-related changes can be blocked by eplerenone. Protein expression of scleraxis, a transcription factor for collagen synthesis, and LC3-II/LC3-I, an index of autophagy, were upregulated in aortas of klotho +/− mice, which can be abolished by eplerenone. In cultured mouse aortic smooth muscle cells, aldosterone increased collagen-1 expression that can be completely eliminated by small interfering RNA knockdown of scleraxis. Interestingly, aldosterone decreased elastin levels in smooth muscle cells, which can be abolished by small interfering RNA knockdown of Beclin-1, an autophagy-related gene. In conclusion, this study demonstrated for the first time that klotho deficiency-induced arterial stiffening may involve aldosterone-mediated upregulation of scleraxis and induction of autophagy, which led to increased collagen-1 expression and decreased elastin levels, respectively. (Hypertension.
and chronic kidney diseases. 19 Therefore, we investigated whether haplodeficiency of klotho causes arterial stiffening. We recently found that haplodeficiency of klotho upregulates adrenal CYP11B2 expression and aldosterone synthesis. 20 Therefore, we planned to investigate whether klotho deficiency causes arterial stiffness by upregulation of aldosterone levels. To study the potential involvement of aldosterone in the regulation of arterial stiffness, we assessed the effect of an aldosterone receptor blocker, eplerenone, on pulse wave velocity (PWV) in klotho +/− mice. We further evaluated scleraxis (collagen transcription factor) and Beclin-1 (autopgagy-related gene) in aldosterone-induced collagen synthesis and elastin degradation in mouse vascular aortic smooth muscle cells (MOVAS).
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. Figure 1A ), indicating that klotho deficiency causes arterial stiffness. After measurement of PWV, mice were euthanized for measuring serum aldosterone levels. Notably, serum aldosterone levels were higher in klotho +/− mice than those in WT mice ( Figure 1B) . Therefore, klotho deficiency increases circulating aldosterone levels.
Results

Haplodeficiency of
In another experiment, we monitored PWV and systolic blood pressure (BP) in mice aged 14 to 16 weeks. PWV started to increase in klotho +/− mice around 14 weeks, whereas BP did not increase significantly by 16 weeks of age ( Figure S1A and S1B in the online-only Data Supplement). This result indicated that arterial stiffening preceded the development of elevation of BP. Western blot analysis indicated that klotho protein expression was decreased significantly in kidneys and adrenal glands ( Figure S2 ), which is consistent with our recent studies. (Figure 2 ). Eplerenone did not affect PWV in WT mice (Figure 2) . The results suggest that upregulation of aldosterone levels may be involved in arterial stiffening because of klotho deficiency. Eplerenone did not affect body weight either in WT or in klotho +/− mice ( Figure S3 ).
Haplodeficiency of Klotho Gene Increased Collagen Expression but Decreased Elastin Levels in Aortas That Can Be Abolished by Blockade of Aldosterone Receptors
To investigate the molecular basis of arterial stiffening, we measured arterial collagen and elastin levels by immunostaining and Western blot assays. [22] [23] [24] The immunostaining assay showed that aortic collagen expression levels increased significantly in klotho +/− mice ( Figure 3A ). Collagen deposition (blue) in klotho +/− mice was mainly found in the medial layer of the aorta. However, aortic elastin levels (brown) were decreased significantly in klotho +/− mice ( Figure 3A ). Collagen staining was increased in aortas but not in small arteries (carotid and femoral arteries) in klotho +/− mice ( Figure S4 ), suggesting that klotho deficiency causes remodeling primarily in large conduit arteries. Western blot analysis confirmed that klotho deficiency upregulated collagen I expression but downregulated elastin levels in aortas ( Figure 3B ). The ratio of elastin/collagen in aortas was markedly decreased in klotho +/− mice ( Figure 3A and 3B), indicating that klotho deficiency causes arterial remodeling. Blockade of aldosterone receptors by eplerenone abolished the upregulation of collagen and downregulation of elastin in aortas leading to attenuation of arterial remodeling in klotho +/− mice. Eplerenone did not affect the ratio of elastin/collagen in WT mice ( Figure 3 ).
Haplodeficiency of Klotho Gene Increased Arterial Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Transforming Growth Factor-β1 Expression That Can Be Eliminated by Blockade of Aldosterone Receptors
Matrix metalloproteinases (MMPs) are a family of proteases that play important roles in extracellular matrix remodeling and degradation. Increased MMP activity could contribute to extracellular matrix remodeling and fibrosis. The immunostaining assay showed that expression of MMP2 and MMP9 was localized in smooth muscle layers ( Figure 4A ). We further measured MMP protein expression levels by Western blots. MMP2 and MMP9 protein expressions were increased significantly in aortas of klotho +/− mice ( Figure 4B ). Blockade of aldosterone receptors by eplerenone decreased MMP2 and MMP9 expressions to the control levels ( Figure 4B ). Eplerenone did not affect MMP2 and MMP9 expressions in WT mice ( Figure 4B ).
Transforming growth factor-β (TGF-β) increases matrix protein synthesis and decreases matrix protein degradation, catalyzed by several enzyme families, including MMPs, resulting in tissue fibrosis. 25 Western blot analysis showed that TGF-β1 expression was increased significantly in klotho 
Aldosterone Increased Collagen-1 Expression in Smooth Muscle Cells by Upregulation of Transcriptional Factor Scleraxis
One of the interesting findings is that scleraxis was upregulated in aortas of klotho +/− mice ( Figure S5A ). Blockade of aldosterone receptors by eplerenone decreased scleraxis expression in klotho +/− mice to the control level ( Figure S5A ), suggesting that klotho deficiency-induced upregulation of scleraxis was mediated by aldosterone. Scleraxis is a transcription factor that is implicated in regulating the development of collagen-rich tissues, such as tendons. 26, 27 However, whether it is involved in the collagen synthesis in arterial cells is not clear.
To answer this question, MOVAS were treated with aldosterone for 16 hours and then harvested for Western blot analysis. Aldosterone increased scleraxis expression and collagen-1 expression in MOVAS ( Figure S5B ). To investigate whether scleraxis plays a role in aldosteroneinduced upregulation of collagen-1, we silenced scleraxis in MOVAS. Scleraxis small interfering RNA (siRNA) was effective in knocking down scleraxis ( Figure S5C ). Briefly, MOVAS were transfected with scleraxis siRNA for 48 hours before treatment with aldosterone for another 16 hours. Aldosterone increased collagen-1 and scleraxis expression levels in MOVAS. siRNA-mediated knockdown of scleraxis completely eliminated upregulation of collagen-1 induced by aldosterone ( Figure S5D ). Scleraxis siRNA did not affect the inhibitory effect of aldosterone on elastin expression in MOVAS ( Figure 6D ). These results suggest that upregulation of scleraxis may mediate the aldosterone-induced increase in collagen-1 expression in MOVAS.
Aldosterone Decreased Elastin Levels in Smooth Muscle Cells Through Induction of Autophagy
The ratio of LC3-II/LC3-I, a reliable marker of autophagy, was upregulated in aortas of klotho +/− mice ( Figure S6A ). Blockade of aldosterone receptors by eplerenone abolished klotho deficiency-induced upregulation of the ratio of LC3-II/LC3-I. In cultured MOVAS, aldosterone increased the ratio of LC3-II/LC3-I and decreased elastin expression ( Figure S6B ).
To assess whether autophagy plays a role in aldosteroneinduced downregulation of elastin, we silenced Beclin-1, an autophagy-related gene. Beclin-1 siRNA effectively knocked down Beclin-1 and inhibited autophagy in MOVAS ( Figure  S6C ). Briefly, MOVAS were transfected with Beclin-1 siRNA for 48 hours before treatment with aldosterone for another 16 hours. Aldosterone upregulated Beclin-1, elastase, MMP2, and MMP9 expression but decreased elastin levels in MOVAS ( Figure S6D ). These changes were abolished by siRNA knockdown of Beclin-1 ( Figure S6D ), suggesting that autophay may be involved in elastin degradation induced by aldosterone. Beclin-1 siRNA did not affect the promoting effect of aldosterone on collagen-1 expression in MOVAS ( Figure S6D ).
Discussion
Klotho was originally identified as an aging-suppressor gene. 3 Mutation of klotho gene causes multiple premature aging phenotypes and shortens lifespan. 1 This study demonstrates, for the first time, that haplodeficiency of klotho gene caused arterial stiffening. Arterial stiffening is one of the earliest detectable manifestations of adverse structural and functional changes within the vessel wall. 8 An increase in arterial stiffness is an independent risk factor for cardiovascular morbidity and mortality. 7, [28] [29] [30] [31] In humans, a decrease in the serum level of soluble klotho is an independent biomarker of pronounced arterial stiffness in patients with chronic kidney disease. 19 Conversely, an increase in plasma klotho levels is associated with reduced arterial stiffness in postmenopausal women. 32 This study demonstrated that arterial stiffening occurred before the elevation of BP, suggesting that arterial stiffening was not attributed to hypertension. The recent Framingham study showed that large-artery stiffness precedes the development of hypertension. 33 This report indicated that arterial stiffening may be the cause of hypertension. 33 Two longitudinal studies have demonstrated that arterial stiffness predicts an increase in systolic BP and incident hypertension. 34, 35 High-fat diet-induced arterial stiffening also preceded the development of hypertension. 36 In this study, we showed that hyperaldosteronism may mediate arterial stiffening because of klotho deficiency (Figures 1-5 ). Indeed, a high level of aldosterone itself is sufficient to cause elastin degradation and increase collagen synthesis in smooth muscle cells ( Figure S5 and S6). Although hypertension could also contribute to vascular remodeling and stiffening, it is, however, a slow process. Nevertheless, this study does not exclude the possibility that persistent elevation of BP may also contribute to the progression of arterial stiffening in this model in its later stage. The limitation of this study is that it does not elucidate the relationship of arterial stiffening and hypertension (causality).
Serum levels of klotho decrease with age after the age 40 years, 17 whereas the prevalence of arterial stiffening and hypertension increases with age. 7 Our study provides the first experimental evidence that klotho deficiency may be a pathological factor for arterial stiffness. Klotho +/− mice were used, which mimics a half klotho reduction in the aged population. 17 The development of arterial stiffening in klotho
mice is a slow and gradual structural remodeling process starting at a low level of stiffening (Figure 1 ; Figure S1 ). Arterial stiffening in klotho +/− mice is a natural model, which may be moderate versus other models, for example, the high fat-/high sucrose-induced model. 36 Klotho homozygous (−/−) mice demonstrate early and extensive aging phenotypes and die before the age of 8 weeks (body weight, 8 g). 1 Klotho homozygous mice also develop severe hyperphosphatemia and soft tissue calcification. 3, 4 As a result, klotho homozygous mice were not used.
Interestingly, haplodeficiency of klotho gene increased the level of circulating aldosterone (Figure 1 ), which was supported by an observation by Fischer et al 37 who showed that plasma levels of aldosterone were elevated significantly in klotho −/− mice. Our recent study showed that haplodeficiency of klotho gene upregulates adrenal CYP11B2 expression leading to increased aldosterone synthesis. 20 To investigate whether upregulation of aldosterone levels is involved in klotho deficiency-induced arterial stiffness, we treated klotho +/− mice with an aldosterone receptor blocker, eplerenone. Notably, blockade of the aldosterone action by eplerenone (1) abolished the increase of PWV, (2) largely rescued arterial collagen deposition and elastin degradation, (3) eliminated the increases in arterial MMP2, MMP9, and TGF-β1 expression, and (4) attenuated myofibroblast differentiation in aortas in klotho +/− mice. Together, this study provides the first evidence that klotho deficiency-induced arterial stiffening is mediated by upregulation of aldosterone levels.
Using MOVAS, we further investigated the molecular mechanism of klotho deficiency-induced upregulation of collagen expression and downregulation of elastin levels, the critical basis of arterial stiffness. Scleraxis, a member of the basic helix-loop-helix family of transcription factors, is specifically expressed in tendons and ligaments, where it can be detected from early progenitor cells to mature fibroblasts. [38] [39] [40] Scleraxis is sufficient to upregulate expression of the collagen 1α2 gene in primary cardiac fibroblasts. 41, 42 Indeed, scleraxis regulates expression of the collagen 1α1 gene in tenocytes, and scleraxis gene deletion results in defects in the development of intermuscular and force-transmitting tendons concomitant with type I collagen loss. 26, 27 We showed that scleraxis was upregulated in the aorta of klotho +/− mice ( Figure S5 ). Interestingly, blockade of aldosterone receptors by eplerenone abolished the upregulation of scleraxis expression, suggesting that aldosterone may be involved in klotho deficiency-induced upregulation of scleraxis. Although aldosterone is known to increase arterial stiffening, 16 the underlying mechanism is unclear. In cultured MOVAS, aldosterone increased scleraxis expression and collagen-1 expression. Scleraxis may mediate aldosterone-induced upregulation of collagen-1 expression, which can be eliminated by siRNA knockdown of scleraxis. This is the first study demonstrating that scleraxis is expressed in aortic SMCs and may be involved in collagen synthesis. In addition, the findings reveal a previously unidentified role of aldosterone in regulating the expression of scleraxis, a key transcription factor for collagen synthesis.
Autophagy is a primary cellular pathway for lysosomal degradation and recycling of long-lived proteins and organelles. Autophagy plays an important role in maintaining cell and organ homeostasis under both basal and various stressful conditions. 43, 44 Accumulating evidence suggests that aldosterone may induce autophagy to remove protein aggregation. 45, 46 However, whether autophagy causes extracellular matrix protein changes and contributes to arterial stiffening has never been investigated. We demonstrate that klotho deficiency upregulated autophagy in aortas, which was mediated by aldosterone ( Figure S6 ). In cultured SMCs, aldosterone induced autophagy and increased elastase, MMP2, and MMP9 expression leading to decreased elastin levels ( Figure S6 ). We showed that upregulation of autophagy may mediate aldosterone-induced degradation of elastin because inhibition of autophagy by siRNA knockdown of Beclin-1 abolished aldosterone-induced upregulation of elastase, MMP2, and MMP9 expression and downregulation of elastin. This is the first report showing that autophagy may induce elastin degradation. Further studies are warranted to assess the relationship of Beclin-1 and elastase/MMPs.
Perspectives
Our study provides the first experimental evidence that arterial stiffness because of klotho deficiency is mediated by upregulation of aldosterone levels that increase scleraxis expression and induce autophagy. It is new and interesting that klotho deficiency-induced upregulation of scleraxis expression and induction of autophagy induce collagen synthesis and elastin degradation, respectively. Accumulation of stiffer collagen and degeneration of compliant elastin fibers are considered the key structural remodeling contributing to arterial stiffening. were euthanized (ketamine/xylazine, 90/10 mg, IP). Blood was collected for measuring serum levels of aldosterone.
Supplemental Materials and Methods
Animal Study Protocols
For the interventional study, 14 klotho +/-mice and 14 aged-matched WT littermates were used (15 mo). Each strain of mice was divided into two subgroups. One subgroup received eplerenone (6 mg/kg/day, IP) while the other received an equal volume of DMSO (dimethyl sulfoxide, 5%) and served as a control. Pulse wave velocity (PWV) was measured before and after treatment with eplerenone for 3 weeks. All animals were sacrificed and perfused transcardially with PBS under deep anesthesia (ketamine/xylazine, 90/10 mg, IP). Before perfusion, blood was collected for measuring plasma klotho level. The aortas were then quickly removed, washed, and cut into pieces for subsequent analyses. ®CRL-2797 ) is a continuous mouse aortic vascular smooth muscle cell line that has been demonstrated to retain a VSMC-like phenotype, including a spindle cell morphology and the expression of VSMC-specific markers such as smooth muscle α-actin and SM22-α. MOVAS were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 2mM L-glutamine. The silencer select siRNAs targeting mouse scleraxis (catalog no. sc-153257), Beclin-1 (catalog no. sc-29798), and a silencer negative control siRNA-A (catalog no. sc-37007) were obtained from Santa Cruz (Austin, TX). For transfection, cells were plated in 60-mm tissue culture dishes at 0.7×10 6 cells per dish, grown for 24 h, and then transfected with siRNA at a final concentration of 10 nM using Lipofectamine RNAiMAX and Opti-MEM in serum-free and antibiotic-free medium, according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). The media were replaced 48 h later with fresh 2% serum containing DMEM, and the cells were then treated with 10 μM aldosterone for another 16 h.
Cell Culture and Treatment
MOVAS (ATCC
Measurement of Pulse Wave Velocity
3
Aortic PWV was measured as described previously. [2] [3] Briefly, mice were anesthetized under 2% isoflurane in a closed chamber anesthesia machine (SomnoSuite, Kent Scientific, Torrington, CT) for ~1-3 min. Anesthesia was maintained via nose cone, and mice were secured in a supine position on a heating board (~37°C) to maintain body temperature. Velocities were measured with 6-mm crystal 20-MHz Doppler probes (Indus Instruments, Webster, TX) at the transverse aortic arch and ~ 3.5 cm distal at the abdominal aorta and collected using Doppler signal processing workstation (Indus Instruments). Absolute pulse arrival times were indicated by the sharp upstroke, or foot, of each velocity waveform. Aortic PWV is then calculated as the quotient of the separation distance, assessed to the nearest half millimeter by engineering caliper and difference in absolute arrival times.
Measurement of Serum Aldosterone Level
Serum aldosterone levels were measured using an aldosterone ELISA kit (10004377, Cayman Chemical Company, Ann Arbor, MI, USA) according to the manufacturer's instruction.
Histological and immunohistochemical staining
Thoracic aortas were quickly excised and placed in cold (4°C) physiological saline solution. Three millimeter rings with perivascular tissue intact were removed from the thoracic aorta directly distal to the greater curvature of the aortic arch. Aorta rings were post-fixed in 4% paraformaldehyde, embedded in paraffin and sectioned at 5 μm thickness. Collagen was quantified by masson's trichrome staining as described previously. 4 The blue staining represented collagen deposition. A series of 10-15 sections of each mouse (5 mice per group) were examined and photographed using an Olympus BH-L microscope coupled with a digital color camera. Blue-stained collagen areas were quantified with ImageJ (NIH, Bethesda, MA) from 4-5 regions per section. The same threshold was used for each photo to make sure they are comparable.. Elastin was assessed by immunohistochemical visualization. Briefly, sections are washed and incubated in primary antibody against elastin (1:50, Abcam, Cambridge, MA, USA) or negative control (2.5% horse serum, Vector Labs) overnight and elastin was visualized using the appropriate secondary antibody. Finally, a series of 5-10 sections were examined and photographed using an Olympus BH-L microscope coupled with a digital color camera. Elastin levels were quantified using the Image J software (NIH, Bethesda, MD) from 4-5 regions per section. The threshold for positive staining was determined based on the negative staining (background). The same procedure was used for quantifying staining density for each animal to ensure that the data are comparable. MMP2 and MMP9 expression and myofibroblasts differentiation were also assessed by immunohistochemical staining with their primary antibody against MMP2, MMP9 and α-SMA (1:100, Abcam, Cambridge, MA, USA), respectively.
Western Blot Analysis
Protein samples from the thoracic aorta were prepared in lysis buffer as described previously. [5] [6] The proteins (40-50 mg) were resolved by SDS-PAGE and transferred to a nitrocellulose membrane (Bio-Rad). The membrane was then incubated overnight (4°C) with a primary antibody against collagen-1, elastin, elastase, MMP2, MMP9 (Abcam, 1:1000), TGFβ-1, scleraxis (Santa Cruz, 1:100), Beclin-1, LC3B, or α-Tubulin (Cell Signaling, 1:1000). Goat anti-mouse or goat anti-rabbit horseradish peroxidase (1:2000-1:5,000; Santa Cruz Biotechnology) was used as a secondary antibody and incubated for 1 hour at room temperature. Specific proteins were detected by chemiluminescent methods using Amersham TM ECL TM western blotting detection reagents (GE Healthcare, UK). Protein abundance on western blots was quantified by densitometry using Image lab software (Bio-Rad, Hercules, CA).
Statistical Analysis
Quantitative data were presented as the Means±SE. Differences between experimental groups were examined by one-way or two-way analysis of variance (ANOVA) followed by the Bonferroni post-test using Prism software (GraphPad). For all analysis, p<0.05 were considered statistically significant.
